{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:05:40Z","timestamp":1794276340704,"version":"4.9.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T00:00:00Z","timestamp":1534291200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Emmanuel van der Schueren research grant from Kom op tegen Kanker (Stand up to Cancer), the Flemish cancer society"},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"crossref","award":["G.0621.10"],"award-info":[{"award-number":["G.0621.10"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13046-018-0860-x","type":"journal-article","created":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T08:19:48Z","timestamp":1534321188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer"],"prefix":"10.1186","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7763-2888","authenticated-orcid":false,"given":"Jonas","family":"Steenbrugge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Breyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristel","family":"Demeyere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"De Wever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niek N.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Van Den Broeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Colpaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Van Laere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,15]]},"reference":[{"issue":"10087","key":"860_CR1","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1016\/S0140-6736(16)32454-0","volume":"389","author":"C Denkert","year":"2017","unstructured":"Denkert C, Liedtke C, Tutt A, von Minckwitz G. Molecular alterations in triple-negative breast cancer-the road to new treatment strategies. Lancet. 2017;389(10087):2430\u201342.","journal-title":"Lancet"},{"issue":"4","key":"860_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s10555-016-9654-9","volume":"35","author":"A Spellman","year":"2016","unstructured":"Spellman A, Tang SC. Immunotherapy for breast cancer: past, present, and future. Cancer Metastasis Rev. 2016;35(4):525\u201346.","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"860_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12032-017-1071-6","volume":"35","author":"H Katz","year":"2017","unstructured":"Katz H, Alsharedi M. Immunotherapy in triple-negative breast cancer. Med Oncol. 2017;35(1):13.","journal-title":"Med Oncol"},{"issue":"7","key":"860_CR4","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1093\/annonc\/mdw041","volume":"27","author":"MF Sanmamed","year":"2016","unstructured":"Sanmamed MF, Chester C, Melero I, Kohrt H. Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapies. Ann Oncol. 2016;27(7):1190\u20138.","journal-title":"Ann Oncol"},{"issue":"18","key":"860_CR5","doi-asserted-by":"publisher","first-page":"5288","DOI":"10.1158\/0008-5472.CAN-16-0194","volume":"76","author":"J Liu","year":"2016","unstructured":"Liu J, Blake SJ, Harjunpaa H, Fairfax KA, Yong MC, Allen S, et al. Assessing immune-related adverse events of efficacious combination immunotherapies in preclinical models of Cancer. Cancer Res. 2016;76(18):5288\u2013301.","journal-title":"Cancer Res"},{"issue":"3\u20134","key":"860_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10911-016-9362-7","volume":"21","author":"J Steenbrugge","year":"2016","unstructured":"Steenbrugge J, Breyne K, Denies S, Dekimpe M, Demeyere K, De Wever O, et al. Comparison of the adipose and luminal mammary gland compartment as Orthotopic inoculation sites in a 4T1-based immunocompetent preclinical model for triple-negative breast Cancer. J Mammary Gland Biol Neoplasia. 2016;21(3\u20134):113\u201322.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"2","key":"860_CR7","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1158\/0008-5472.CAN-05-4005","volume":"66","author":"CE Lewis","year":"2006","unstructured":"Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 2006;66(2):605\u201312.","journal-title":"Cancer Res"},{"key":"860_CR8","doi-asserted-by":"crossref","unstructured":"Williams CB, Yeh ES, Soloff AC. Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy. NPJ Breast Cancer. 2016;2","DOI":"10.1038\/npjbcancer.2015.25"},{"issue":"11","key":"860_CR9","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","volume":"23","author":"A Mantovani","year":"2002","unstructured":"Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002;23(11):549\u201355.","journal-title":"Trends Immunol"},{"issue":"31","key":"860_CR10","doi-asserted-by":"publisher","first-page":"50731","DOI":"10.18632\/oncotarget.14913","volume":"8","author":"EC Carron","year":"2017","unstructured":"Carron EC, Homra S, Rosenberg J, Coffelt SB, Kittrell F, Zhang Y, et al. Macrophages promote the progression of premalignant mammary lesions to invasive cancer. Oncotarget. 2017;8(31):50731\u201346.","journal-title":"Oncotarget"},{"issue":"1","key":"860_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41467-017-02481-5","volume":"9","author":"N Linde","year":"2018","unstructured":"Linde N, Casanova-Acebes M, Sosa MS, Mortha A, Rahman A, Farias E, et al. Macrophages orchestrate breast cancer early dissemination and metastasis. Nat Commun. 2018;9(1):21.","journal-title":"Nat Commun"},{"issue":"2","key":"860_CR12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1158\/1055-9965.EPI-05-0011","volume":"15","author":"JS Johansen","year":"2006","unstructured":"Johansen JS, Jensen BV, Roslind A, Nielsen D, Price PA. Serum YKL-40, a new prognostic biomarker in cancer patients? Cancer Epidemiol Biomark Prev. 2006;15(2):194\u2013202.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"3","key":"860_CR13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s10549-007-9619-3","volume":"108","author":"M Bauer","year":"2008","unstructured":"Bauer M, Eickhoff JC, Gould MN, Mundhenke C, Maass N, Friedl A. Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer. Breast Cancer Res Treat. 2008;108(3):389\u201397.","journal-title":"Breast Cancer Res Treat"},{"key":"860_CR14","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1186\/1471-2407-9-390","volume":"9","author":"X Provatopoulou","year":"2009","unstructured":"Provatopoulou X, Gounaris A, Kalogera E, Zagouri F, Flessas I, Goussetis E, et al. Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9\/NGAL in breast cancer disease. BMC Cancer. 2009;9:390.","journal-title":"BMC Cancer"},{"key":"860_CR15","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/1471-2407-8-228","volume":"8","author":"K Tao","year":"2008","unstructured":"Tao K, Fang M, Alroy J, Sahagian GG. Imagable 4T1 model for the study of late stage breast cancer. BMC Cancer. 2008;8:228.","journal-title":"BMC Cancer"},{"key":"860_CR16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1471-2407-12-120","volume":"12","author":"P Kaur","year":"2012","unstructured":"Kaur P, Nagaraja GM, Zheng H, Gizachew D, Galukande M, Krishnan S, et al. A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease. BMC Cancer. 2012;12:120.","journal-title":"BMC Cancer"},{"issue":"10","key":"860_CR17","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1002\/dvdy.21658","volume":"237","author":"Y Lou","year":"2008","unstructured":"Lou Y, Preobrazhenska O, auf dem Keller U, Sutcliffe M, Barclay L, PC MD, et al. Epithelial-mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis. Dev Dyn. 2008;237(10):2755\u201368.","journal-title":"Dev Dyn"},{"issue":"9","key":"860_CR18","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-10-4261","volume":"71","author":"Y Lou","year":"2011","unstructured":"Lou Y, McDonald PC, Oloumi A, Chia S, Ostlund C, Ahmadi A, et al. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. Cancer Res. 2011;71(9):3364\u201376.","journal-title":"Cancer Res"},{"issue":"24","key":"860_CR19","doi-asserted-by":"publisher","first-page":"36666","DOI":"10.18632\/oncotarget.9134","volume":"7","author":"S Faes","year":"2016","unstructured":"Faes S, Planche A, Uldry E, Santoro T, Pythoud C, Stehle JC, et al. Targeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitors. Oncotarget. 2016;7(24):36666\u201380.","journal-title":"Oncotarget"},{"issue":"4","key":"860_CR20","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/bcr1530","volume":"8","author":"A Fantozzi","year":"2006","unstructured":"Fantozzi A, Christofori G. Mouse models of breast cancer metastasis. Breast Cancer Res. 2006;8(4):212.","journal-title":"Breast Cancer Res"},{"issue":"2\u20133","key":"860_CR21","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10911-007-9050-8","volume":"12","author":"J Jonkers","year":"2007","unstructured":"Jonkers J, Derksen PW. Modeling metastatic breast cancer in mice. J Mammary Gland Biol Neoplasia. 2007;12(2\u20133):191\u2013203.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"5","key":"860_CR22","doi-asserted-by":"publisher","first-page":"R66","DOI":"10.1186\/bcr2358","volume":"11","author":"F Behbod","year":"2009","unstructured":"Behbod F, Kittrell FS, LaMarca H, Edwards D, Kerbawy S, Heestand JC, et al. An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ. Breast Cancer Res. 2009;11(5):R66.","journal-title":"Breast Cancer Res"},{"issue":"4","key":"860_CR23","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/path.2969","volume":"225","author":"KE Valdez","year":"2011","unstructured":"Valdez KE, Fan F, Smith W, Allred DC, Medina D, Behbod F. Human primary ductal carcinoma in situ (DCIS) subtype-specific pathology is preserved in a mouse intraductal (MIND) xenograft model. J Pathol. 2011;225(4):565\u201373.","journal-title":"J Pathol"},{"issue":"2","key":"860_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s10911-012-9259-z","volume":"17","author":"D Medina","year":"2012","unstructured":"Medina D, Edwards DG, Kittrell F, Lee S, Allred DC. Intra-mammary ductal transplantation: a tool to study premalignant progression. J Mammary Gland Biol Neoplasia. 2012;17(2):131\u20133.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"11","key":"860_CR25","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1016\/j.ajpath.2015.07.004","volume":"185","author":"TD Russell","year":"2015","unstructured":"Russell TD, Jindal S, Agunbiade S, Gao D, Troxell M, Borges VF, et al. Myoepithelial cell differentiation markers in ductal carcinoma in situ progression. Am J Pathol. 2015;185(11):3076\u201389.","journal-title":"Am J Pathol"},{"issue":"3","key":"860_CR26","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ccell.2016.02.002","volume":"29","author":"G Sflomos","year":"2016","unstructured":"Sflomos G, Dormoy V, Metsalu T, Jeitziner R, Battista L, Scabia V, et al. A preclinical model for ERalpha-positive breast Cancer points to the epithelial microenvironment as determinant of luminal phenotype and hormone response. Cancer Cell. 2016;29(3):407\u201322.","journal-title":"Cancer Cell"},{"issue":"3","key":"860_CR27","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/path.4772","volume":"240","author":"E Richard","year":"2016","unstructured":"Richard E, Grellety T, Velasco V, MacGrogan G, Bonnefoi H, Iggo R. The mammary ducts create a favourable microenvironment for xenografting of luminal and molecular apocrine breast tumours. J Pathol. 2016;240(3):256\u201361.","journal-title":"J Pathol"},{"issue":"4","key":"860_CR28","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.devcel.2017.10.027","volume":"43","author":"SS Bajikar","year":"2017","unstructured":"Bajikar SS, Wang CC, Borten MA, Pereira EJ, Atkins KA, Janes KA. Tumor-suppressor inactivation of GDF11 occurs by precursor sequestration in triple-negative breast Cancer. Dev Cell. 2017;43(4):418\u201335. e13","journal-title":"Dev Cell"},{"issue":"4","key":"860_CR29","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nrc1839","volume":"6","author":"P Schedin","year":"2006","unstructured":"Schedin P. Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer. 2006;6(4):281\u201391.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"860_CR30","doi-asserted-by":"publisher","first-page":"608","DOI":"10.2353\/ajpath.2006.050677","volume":"168","author":"SM McDaniel","year":"2006","unstructured":"McDaniel SM, Rumer KK, Biroc SL, Metz RP, Singh M, Porter W, et al. Remodeling of the mammary microenvironment after lactation promotes breast tumor cell metastasis. Am J Pathol. 2006;168(2):608\u201320.","journal-title":"Am J Pathol"},{"key":"860_CR31","doi-asserted-by":"publisher","first-page":"4549676","DOI":"10.1155\/2016\/4549676","volume":"2016","author":"NJ Brady","year":"2016","unstructured":"Brady NJ, Chuntova P, Schwertfeger KL. Macrophages: regulators of the inflammatory microenvironment during mammary gland development and breast Cancer. Mediat Inflamm. 2016;2016:4549676.","journal-title":"Mediat Inflamm"},{"issue":"3","key":"860_CR32","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/path.4845","volume":"241","author":"VL Bridgeman","year":"2017","unstructured":"Bridgeman VL, Vermeulen PB, Foo S, Bilecz A, Daley F, Kostaras E, et al. Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models. J Pathol. 2017;241(3):362\u201374.","journal-title":"J Pathol"},{"issue":"3","key":"860_CR33","doi-asserted-by":"publisher","first-page":"e0121921","DOI":"10.1371\/journal.pone.0121921","volume":"10","author":"M Liu","year":"2015","unstructured":"Liu M, Jin X, He X, Pan L, Zhang X, Zhao Y. Macrophages support splenic erythropoiesis in 4T1 tumor-bearing mice. PLoS One. 2015;10(3):e0121921.","journal-title":"PLoS One"},{"issue":"1","key":"860_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.yexmp.2006.06.007","volume":"82","author":"SA DuPre","year":"2007","unstructured":"DuPre SA, Hunter KW Jr. Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: association with tumor-derived growth factors. Exp Mol Pathol. 2007;82(1):12\u201324.","journal-title":"Exp Mol Pathol"},{"issue":"4","key":"860_CR35","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.4049\/jimmunol.180.4.2011","volume":"180","author":"SK Biswas","year":"2008","unstructured":"Biswas SK, Sica A, Lewis CE. Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms. J Immunol. 2008;180(4):2011\u20137.","journal-title":"J Immunol"},{"issue":"1","key":"860_CR36","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nrc1256","volume":"4","author":"JW Pollard","year":"2004","unstructured":"Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 2004;4(1):71\u20138.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"860_CR37","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/onc.2009.308","volume":"29","author":"YP Luo","year":"2010","unstructured":"Luo YP, Zhou H, Krueger J, Kaplan C, Liao D, Markowitz D, et al. The role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression. Oncogene. 2010;29(5):662\u201373.","journal-title":"Oncogene"},{"issue":"6","key":"860_CR38","doi-asserted-by":"publisher","first-page":"e65896","DOI":"10.1371\/journal.pone.0065896","volume":"8","author":"X Zhang","year":"2013","unstructured":"Zhang X, Tian W, Cai X, Wang X, Dang W, Tang H, et al. Hydrazinocurcumin Encapsuled nanoparticles \u201cre-educate\u201d tumor-associated macrophages and exhibit anti-tumor effects on breast cancer following STAT3 suppression. PLoS One. 2013;8(6):e65896.","journal-title":"PLoS One"},{"issue":"8","key":"860_CR39","doi-asserted-by":"publisher","first-page":"e105680","DOI":"10.1371\/journal.pone.0105680","volume":"9","author":"K Breyne","year":"2014","unstructured":"Breyne K, Cool SK, Demon D, Demeyere K, Vandenberghe T, Vandenabeele P, et al. Non-classical proIL-1beta activation during mammary gland infection is pathogen-dependent but caspase-1 independent. PLoS One. 2014;9(8):e105680.","journal-title":"PLoS One"},{"key":"860_CR40","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.vetmic.2016.02.014","volume":"186","author":"V Peton","year":"2016","unstructured":"Peton V, Breyne K, Rault L, Demeyere K, Berkova N, Meyer E, et al. Disruption of the sigS gene attenuates the local innate immune response to Staphylococcus aureus in a mouse mastitis model. Vet Microbiol. 2016;186:44\u201351.","journal-title":"Vet Microbiol"},{"key":"860_CR41","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3389\/fimmu.2017.00833","volume":"8","author":"K Breyne","year":"2017","unstructured":"Breyne K, Steenbrugge J, Demeyere K, Vanden Berghe T, Meyer E. Preconditioning with lipopolysaccharide or Lipoteichoic acid protects against Staphylococcus aureus mammary infection in mice. Front Immunol. 2017;8:833.","journal-title":"Front Immunol"},{"key":"860_CR42","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3389\/fimmu.2018.01143","volume":"9","author":"K Breyne","year":"2018","unstructured":"Breyne K, Steenbrugge J, Demeyere K, Lee CG, Elias JA, Petzl W, et al. Immunomodulation of host Chitinase 3-like 1 during a mammary pathogenic Escherichia coli infection. Front Immunol. 2018;9:1143.","journal-title":"Front Immunol"},{"issue":"4","key":"860_CR43","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/jlb.54.4.360","volume":"54","author":"JP van Netten","year":"1993","unstructured":"van Netten JP, Ashmead BJ, Parker RL, Thornton IG, Fletcher C, Cavers D, et al. Macrophage-tumor cell associations: a factor in metastasis of breast cancer? J Leukoc Biol. 1993;54(4):360\u20132.","journal-title":"J Leukoc Biol"},{"issue":"28","key":"860_CR44","doi-asserted-by":"crossref","first-page":"25295","DOI":"10.18632\/oncotarget.4716","volume":"6","author":"J Bai","year":"2015","unstructured":"Bai J, Adriani G, Dang TM, Tu TY, Penny HX, Wong SC, et al. Contact-dependent carcinoma aggregate dispersion by M2a macrophages via ICAM-1 and beta2 integrin interactions. Oncotarget. 2015;6(28):25295\u2013307.","journal-title":"Oncotarget"},{"issue":"5","key":"860_CR45","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.cell.2010.07.044","volume":"142","author":"MP Chao","year":"2010","unstructured":"Chao MP, Alizadeh AA, Tang C, Myklebust JH, Varghese B, Gill S, et al. Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma. Cell. 2010;142(5):699\u2013713.","journal-title":"Cell"},{"issue":"3","key":"860_CR46","doi-asserted-by":"publisher","first-page":"R81","DOI":"10.1186\/bcr3195","volume":"14","author":"HJ Cho","year":"2012","unstructured":"Cho HJ, Jung JI, Lim DY, Kwon GT, Her S, Park JH, et al. Bone marrow-derived, alternatively activated macrophages enhance solid tumor growth and lung metastasis of mammary carcinoma cells in a Balb\/C mouse orthotopic model. Breast Cancer Res. 2012;14(3):R81.","journal-title":"Breast Cancer Res"},{"issue":"7637","key":"860_CR47","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"DS Chen","year":"2017","unstructured":"Chen DS, Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature. 2017;541(7637):321\u201330.","journal-title":"Nature"},{"issue":"2","key":"860_CR48","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/ijc.26379","volume":"131","author":"S Libreros","year":"2012","unstructured":"Libreros S, Garcia-Areas R, Shibata Y, Carrio R, Torroella-Kouri M, Iragavarapu-Charyulu V. Induction of proinflammatory mediators by CHI3L1 is reduced by chitin treatment: decreased tumor metastasis in a breast cancer model. Int J Cancer. 2012;131(2):377\u201386.","journal-title":"Int J Cancer"},{"issue":"1\u20133","key":"860_CR49","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s12026-013-8459-y","volume":"57","author":"S Libreros","year":"2013","unstructured":"Libreros S, Garcia-Areas R, Iragavarapu-Charyulu V. CHI3L1 plays a role in cancer through enhanced production of pro-inflammatory\/pro-tumorigenic and angiogenic factors. Immunol Res. 2013;57(1\u20133):99\u2013105.","journal-title":"Immunol Res"},{"issue":"1","key":"860_CR50","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13045-017-0408-0","volume":"10","author":"Y Chen","year":"2017","unstructured":"Chen Y, Zhang S, Wang Q, Zhang X. Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein. J Hematol Oncol. 2017;10(1):36.","journal-title":"J Hematol Oncol"},{"issue":"31","key":"860_CR51","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1038\/onc.2017.65","volume":"36","author":"N Cohen","year":"2017","unstructured":"Cohen N, Shani O, Raz Y, Sharon Y, Hoffman D, Abramovitz L, et al. Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1. Oncogene. 2017;36(31):4457\u201368.","journal-title":"Oncogene"},{"issue":"22","key":"860_CR52","doi-asserted-by":"publisher","first-page":"8579","DOI":"10.1158\/0008-5472.CAN-09-1934","volume":"69","author":"X Leng","year":"2009","unstructured":"Leng X, Ding T, Lin H, Wang Y, Hu L, Hu J, et al. Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis. Cancer Res. 2009;69(22):8579\u201384.","journal-title":"Cancer Res"},{"issue":"3","key":"860_CR53","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/path.4724","volume":"239","author":"B Oren","year":"2016","unstructured":"Oren B, Urosevic J, Mertens C, Mora J, Guiu M, Gomis RR, et al. Tumour stroma-derived lipocalin-2 promotes breast cancer metastasis. J Pathol. 2016;239(3):274\u201385.","journal-title":"J Pathol"},{"issue":"434","key":"860_CR54","doi-asserted-by":"publisher","first-page":"ra64","DOI":"10.1126\/scisignal.aaf3241","volume":"9","author":"M Jung","year":"2016","unstructured":"Jung M, Oren B, Mora J, Mertens C, Dziumbla S, Popp R, et al. Lipocalin 2 from macrophages stimulated by tumor cell-derived sphingosine 1-phosphate promotes lymphangiogenesis and tumor metastasis. Sci Signal. 2016;9(434):ra64.","journal-title":"Sci Signal"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-018-0860-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13046-018-0860-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-018-0860-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T15:25:20Z","timestamp":1604762720000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-018-0860-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,15]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["860"],"URL":"https:\/\/doi.org\/10.1186\/s13046-018-0860-x","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,15]]},"assertion":[{"value":"21 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"As also stated in the methods section, all research involving animals was performed in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The study protocols were approved by the Committee on the Ethics of Animal Experiments of The Faculty of Veterinary Medicine at Ghent University (approval number: EC2015\/127).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"191"}}